Diagnostic CT-guided online adaptive radiotherapy for locally advanced colon cancer: a prospective implementation and feasibility study [0.03%]
Jun Zhao,Hui Zhang,Lei Yu et al.
Jun Zhao et al.
Purpose: This study aimed to systematically evaluate the geometric, dosimetric, and workflow characteristics of diagnostic CT-guided adaptive radiotherapy for locally advanced colon cancer (LACC), and to assess its feasib...
Assessing the impact of proton versus photon therapy on health-related quality of life in lung cancer [0.03%]
Bradley M Sugden,Willem J A Witlox,Francesco Cortiula et al.
Bradley M Sugden et al.
Background and purpose: A more conformal dose deposition of intensity-modulated proton therapy (IMPT) may enhance health-related quality of life (HRQoL) through reduced radiation-induced toxicities, versus photon-based in...
Outcomes of stereotactic body radiotherapy for supraclavicular lymph node metastasis among patients with metastatic prostate cancer [0.03%]
Andres L Frias,Bradley J Stish,Ryan M Phillips et al.
Andres L Frias et al.
Purpose/objectives: Metastasis directed therapy (MDT) with stereotactic body radiotherapy (SBRT) has demonstrated clinical benefit among select oligometastatic prostate cancer (PCa) patients. The outcomes of SBRT to the l...
Single fraction based-partial breast irradiation: 10-year results of the SiFEBI phase 2 prospective trial [0.03%]
Laura Haas,Jocelyn Gal,Mathieu Gauthier et al.
Laura Haas et al.
Purpose: This analysis updates the SiFEBI phase 2 trial (NCT01727011) evaluating accelerated partial breast irradiation (APBI) delivered as a single fraction (sfPBI) of postoperative multicatheter interstitial HDR brachyt...
De-escalation of elective radiotherapy guided by FDG-PET lowers modeled late swallowing-related toxicity in head and neck cancer [0.03%]
Florian Stritzke,Katharina Dvornikovich,Hin Lau et al.
Florian Stritzke et al.
Purpose: Whether FDG-PET-guided de-escalation of elective target volumes in radiotherapy of the head and neck reduces late toxicity remains uncertain. Therefore, we compared predicted toxicity of two de-escalation strateg...
The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial [0.03%]
Kara M Ruicci,Joelle Helou,Aisling Barry et al.
Kara M Ruicci et al.
Background: Standard-of-care management for patients with progressive metastatic breast cancer is changing systemic therapy lines. For patients with limited disease progression ('oligoprogression'), there is interest in t...
C L Deijen,M Berbée,E D Geijsen et al.
C L Deijen et al.
Introduction: Due to the rarity of anal cancer, real-world data on treatment outcomes are scarce. However, its incidence is increasing in the Netherlands with > 300 new cases and 70 deaths yearly. Standard of care consist...
The complication sum score: A Delphi-based approach to summarize treatment related complications for esophageal cancer [0.03%]
M L Frederiks,M Berbée,B P L Wijnhoven et al.
M L Frederiks et al.
Background and purpose: Prevention of treatment-related complications remains a major challenge in esophageal cancer (EC) patients undergoing neoadjuvant chemoradiotherapy (nCRT) ± surgery. A single measure, reflecting t...
Indication adherence and outcome of post-operative radiotherapy in oral cavity cancer patients with intermediate adverse pathological tumor features: A nationwide population-based analysis [0.03%]
Hanneke Doremiek van Oorschot,Jose Angelito Hardillo,Frank J P Hoebers et al.
Hanneke Doremiek van Oorschot et al.
Purpose: The significance of intermediate-risk adverse pathological features in oral squamous cell carcinoma (OSCC) remains unclear. Consequently, the indications for postoperative radiotherapy (PORT) vary between hospita...
Early tumor shrinkage correlates with final EBRT response in cervical cancer patients treated with MRI-guided radiotherapy [0.03%]
Perla Zidane,Thomas Berger,Angela Boros et al.
Perla Zidane et al.
Background/purpose: Tumor response can vary significantly in locally advanced cervical cancer patients undergoing radiotherapy. Personalizing treatment based on this variability may improve therapeutic outcomes. This stud...